Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Sigma aldrich Co Llc patents


Recent patent applications related to Sigma aldrich Co Llc. Sigma aldrich Co Llc is listed as an Agent/Assignee. Note: Sigma aldrich Co Llc may have other listings under different names/spellings. We're not affiliated with Sigma aldrich Co Llc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Sigma aldrich Co Llc-related inventors


 new patent  Use of endogenous promoters to express heterologous proteins

The present invention provides methods for using endogenous transcriptional control systems to regulate the expression of heterologous protein(s). In particular, targeted genome editing is used to integrate a sequence encoding the heterologous protein(s) in-frame with an endogenous coding sequence such that the expression of the heterologous and endogenous sequences is... Sigma aldrich Co Llc

Directional amplification of rna

Processes, oligonucleotides, and kits for amplifying RNA. In particular, the processes generate and amplify cDNA libraries in which the orientation of the input RNA molecule is preserved in the products. Among the various aspects of the present disclosure is the provision of process for directionally amplifying RNA. The process comprises... Sigma aldrich Co Llc

Nucleic acid amplification and library preparation

Processes and kits for preparing a plurality of amplification products with reduced non-specific amplification artifacts.... Sigma aldrich Co Llc

Visualizing modified nucleotides and nucleic acid interactions in single cells

Methods for visualizing modified nucleotides in a specific nucleic acid sequence or specific nucleic acid sequence interactions in single cells, wherein the methods comprise coupling an in situ hybridization (ISH) reaction with a proximity ligation as say (PLA) reaction.... Sigma aldrich Co Llc

Visualizing modified nucleotides and nucleic acid interactions in single cells

Methods for visualizing modified nucleotides in a specific nucleic acid sequence or specific nucleic acid sequence interactions in single cells, wherein the methods comprise coupling an in situ hybridization (ISH) reaction with a proximity ligation as say (PLA) reaction.... Sigma aldrich Co Llc

Using programmable dna binding proteins to enhance targeted genome modification

Compositions and methods for using programmable DNA binding proteins to increase the efficiency and/or specificity of targeted genome modification or to facilitate the detection of specific genomic loci in eukaryotic cells.... Sigma aldrich Co Llc

Crispr-based genome modification and regulation

The present invention provides RNA-guided endonucleases, which are engineered for expression in eukaryotic cells or embryos, and methods of using the RNA-guided endonuclease for targeted genome modification in eukaryotic cells or embryos. Also provided are fusion proteins, wherein each fusion protein comprises a CRISPR/Cas-like protein or fragment thereof and an... Sigma aldrich Co Llc

Molybdenum silylcyclopentadienyl and silylallyl complexes and use thereof in thin film deposition

Molybdenum complexes and use thereof in thin film deposition, such as CVD and ALD are provided herein. The molybdenum complexes correspond in structure to Formula (I): wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are independently selected from the group consisting of hydrogen, alkyl, and trialkylsilyl;... Sigma aldrich Co Llc

Crispr-based genome modification and regulation

The present invention provides RNA-guided endonucleases, which are engineered for expression in eukaryotic cells or embryos, and methods of using the RNA-guided endonuclease for targeted genome modification in in eukaryotic cells or embryos. Also provided are fusion proteins, wherein each fusion protein comprises a CRISPR/Cas-like protein or fragment thereof and... Sigma aldrich Co Llc

Epigenetic modification of mammalian genomes using targeted endonucleases

The present disclosure provides genetically engineered cell lines comprising chromosomally integrated synthetic sequences having predetermined epigenetic modifications, wherein a predetermined epigenetic modification is correlated with a known diagnosis, prognosis or level of sensitivity to a disease treatment. Also provided are kits comprising said epigenetically modified synthetic nucleic acids or cells... Sigma aldrich Co Llc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Sigma aldrich Co Llc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Sigma aldrich Co Llc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###